Clinical Trial Update: PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study of PNU-93914 in patients with locally advanced or metastatic esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• PNU-93914 (PNU-93914)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED